Title : Crizotinib-resistant NPM-ALK mutants confer differential sensitivity to unrelated Alk inhibitors.

Pub. Date : 2013 Feb

PMID : 23239810






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Crizotinib-resistant NPM-ALK mutants confer differential sensitivity to unrelated Alk inhibitors. Crizotinib nucleophosmin 1 Homo sapiens
2 Here, we focused our attention on the anaplastic large cell lymphoma (ALCL), where the oncogenic fusion protein NPM-ALK, responsible for 70% to 80% of cases, represents an ideal crizotinib target. Crizotinib nucleophosmin 1 Homo sapiens
3 We selected and characterized 2 human NPM-ALK+ ALCL cell lines, KARPAS-299 and SUP-M2, able to survive and proliferate at different crizotinib concentrations. Crizotinib nucleophosmin 1 Homo sapiens
4 These mutations also conferred resistance to crizotinib in Ba/F3 cells expressing human NPM-ALK. Crizotinib nucleophosmin 1 Homo sapiens